Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
87.5M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
10.2M
-
Shares change
-
+9.56M
-
Total reported value, excl. options
-
$86.1M
-
Value change
-
+$80.3M
-
Number of buys
-
12
-
Price
-
$8.40
Significant Holders of Kura Oncology, Inc. - Common Stock (KURA) as of Q4 2015
14 filings reported holding KURA - Kura Oncology, Inc. - Common Stock as of Q4 2015.
Kura Oncology, Inc. - Common Stock (KURA) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.2M shares
of 87.5M outstanding shares and own 11.71% of the company stock.
Largest 10 shareholders include FMR LLC (3.11M shares), EcoR1 Capital, LLC (2.45M shares), Partner Fund Management, L.P. (1.49M shares), Clough Capital Partners L P (1.09M shares), FRANKLIN RESOURCES INC (970K shares), Boxer Capital, LLC (655K shares), VANGUARD GROUP INC (226K shares), Birchview Capital, LP (105K shares), Monashee Investment Management LLC (65.2K shares), and Partner Investment Management, L.P. (48.7K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.